The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors
Open accessAbstract
Oncocytic tumors are a distinctive class of proliferative lesions composed of cells with a striking degree of mitochondrial hyperplasia that are particularly frequent in the thyroid gland. To understand whether specific mitochondrial DNA (mtDNA) mutations are associated with the accumulation of mitochondria, we sequenced the entire mtDNA in 50 oncocytic lesions (45 thyroid tumors of epithelial cell derivation and 5 mitochondrion-rich breast tumors) and 52 control cases (21 nononcocytic thyroid tumors, 15 breast carcinomas, and 16 gliomas) by using recently developed technology that allows specific and reliable amplification of the whole mtDNA with quick mutation scanning. Thirteen oncocytic lesions (26%) presented disruptive mutations (nonsense or frameshift), whereas only two samples (3.8%) presented such mutations in the nononcocytic control group. In one case with multiple thyroid nodules analyzed separately, a disruptive mutation was found in the only nodule with oncocytic features. In one of the five mitochondrion-rich breast tumors, a disruptive mutation was identified. All disruptive mutations were found in complex I subunit genes, and the association between these mutations and the oncocytic phenotype was statistically significant ( P = 0.001). To study the pathogenicity of these mitochondrial mutations, primary cultures from oncocytic tumors and corresponding normal tissues were established. Electron microscopy and biochemical and molecular analyses showed that primary cultures derived from tumors bearing disruptive mutations failed to maintain the mutations and the oncocytic phenotype. We conclude that disruptive mutations in complex I subunits are markers of thyroid oncocytic tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Human non-synonymous SNPs: server and survey
Ramensky, V. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf493 · Cited by 2,280
mtDNA mutations increase tumorigenicity in prostate cancer
Petros, J. A., Baumann, A. K., Ruiz-Pesini, E., Amin, M. B., Sun, C. Q., Hall, J., Lim, S., Issa, M. M., Flanders, W. D., Hosseini, S. H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408894102 · Cited by 836
Mitochondrial mutations in cancer
Brandon, M., Baldi, P., & Wallace, D. C. (2006) · Oncogene · doi:10.1038/sj.onc.1209607 · Cited by 818
WARBURN, O., & DICKENS, F. (1931) · The American Journal of the Medical Sciences · doi:10.1097/00000441-193107000-00022 · Cited by 808
Mitochondrial DNA mutations in human cancer
Chatterjee, A., Mambo, E., & Sidransky, D. (2006) · Oncogene · doi:10.1038/sj.onc.1209604 · Cited by 588
MITOMAP: a human mitochondrial genome database--2004 update
Brandon, M. C. (2004) · Nucleic Acids Research · doi:10.1093/nar/gki079 · Cited by 567
Mitochondrial DNA in human malignancy
Penta, J. S., Johnson, F. M., Wachsman, J. T., & Copeland, W. C. (2001) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(01)00053-9 · Cited by 441
A role for mitochondrial enzymes in inherited neoplasia and beyond
Eng, C., Kiuru, M., Fernandez, M. J., & Aaltonen, L. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1013 · Cited by 392
Simonnet, H. (2002) · Carcinogenesis · doi:10.1093/carcin/23.5.759 · Cited by 347
Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates.
Parrella, P., Xiao, Y., Fliss, M., Sánchez‐Céspedes, M., Mazzarelli, P., Rinaldi, M., Nicol, T. L., Gabrielson, E. W., Cuomo, C., Cohen, D., et al. (2001) · PubMed · Cited by 279
Máximo, V., Soares, P., Lima, J., Cameselle-Teijeiro, J., & Sobrinho-Simões, M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61132-7 · Cited by 271
Robinson, B. H., Petrova-Benedict, R., Buncic, J. R., & Wallace, D. C. (1992) · Biochemical Medicine and Metabolic Biology · doi:10.1016/0885-4505(92)90056-5 · Cited by 266
Mitochondrial DNA G10398A Polymorphism and Invasive Breast Cancer in African-American Women
Canter, J. A., Kallianpur, A. R., Parl, F. F., & Millikan, R. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1428 · Cited by 258
Bonora, E., Porcelli, A. M., Gasparre, G., Biondi, A., Ghelli, A., Carelli, V., Baracca, A., Tallini, G., Martinuzzi, A., Lenaz, G., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0171 · Cited by 225
Self-citationA Critical Reassessment of the Role of Mitochondria in Tumorigenesis
Salas, A., Yao, Y.-G., Macaulay, V., Vega, A., Carracedo, Á., & Bandelt, H.-J. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020296 · Cited by 207
DiMauro, S. (2004) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2004.03.014 · Cited by 200
Carelli, V., Achilli, A., Valentino, M. L., Rengo, C., Semino, O., Pala, M., Olivieri, A., Mattiazzi, M., Pallotti, F., Carrara, F., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/501236 · Cited by 184
Self-citationYeh, J. J., Lunetta, K. L., van Orsouw, N. J., Moore, F. D., Mutter, G. L., Vijg, J., Dahia, P. L., & Eng, C. (2000) · Oncogene · doi:10.1038/sj.onc.1203537 · Cited by 172
Clinical Value of Mitochondrial Mutations in Colorectal Cancer
Lièvre, A., Chapusot, C., Bouvier, A., Zinzindohoué, F., Piard, F., Roignot, P., Arnould, L., Beaune, P. H., Faivre, J., & Laurent‐Puig, P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.044 · Cited by 155
OligoWiz 2.0--integrating sequence feature annotation into the design of microarray probes
Wernersson, R., & Nielsen, H. B. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki399 · Cited by 150
Mitochondrial complex I is deficient in renal oncocytomas
Simonnet, H., Demont, J., Pfeiffer, K., Guenaneche, L., Bouvier, R., Brandt, U., Schägger, H., & Godinot, C. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg109 · Cited by 138
Nuclear genes in mitochondrial disorders
Zeviani, M., Spinazzola, A., & Carelli, V. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00052-2 · Cited by 98
Self-citationCurcio, F., Ambesi‐Impiombato, F. S., Perrella, G., & COON, H. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9004 · Cited by 88
Self-citationBaris, O. R., Savagner, F., Nasser, V., Loriod, B., Granjeaud, S., Guyétant, S., Franc, B., Rodien, P., Rohmer, V., Bertucci, F., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031238 · Cited by 86
Attimonelli, M., Accetturo, M., Santamaría, M., Lascaro, D., Scioscia, G., Pappadà, G., Russo, L., Luigi, Z., & Tommaseo-Ponzetta, M. (2005) · BMC Bioinformatics · doi:10.1186/1471-2105-6-s4-s4 · Cited by 79
Proinflammatory Mediators and Genetic Background in Oncogene Mediated Tumor Progression
Russell, J. P., Engiles, J. B., & Rothstein, J. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4059 · Cited by 62
Mitochondrial disorders in renal tumors
Hervouet, É., & Godinot, C. (2006) · Mitochondrion · doi:10.1016/j.mito.2006.03.003 · Cited by 30
Mitochondrial DNA and Human Thyroid Diseases
Rogounovitch, T., Saenko, V., & Yamashita, S. (2004) · Endocrine Journal · doi:10.1507/endocrj.51.265 · Cited by 22
Cited by
Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation
van Oven, M., & Kayser, M. (2009) · Human Mutation · doi:10.1002/humu.20921 · Cited by 1,810
Overview of the 2022 WHO Classification of Thyroid Neoplasms
Baloch, Z. W., Asa, S. L., Barletta, J. A., Ghossein, R. A., Juhlin, C. C., Jung, C. K., LiVolsi, V. A., Papotti, M. G., Sobrinho-Simões, M., Tallini, G., et al. (2022) · Endocrine Pathology · doi:10.1007/s12022-022-09707-3 · Cited by 1,158
Self-citationMolecular genetics and diagnosis of thyroid cancer
Nikiforov, Y. E., & Nikiforova, M. N. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.142 · Cited by 1,011
Ketogenic diet in the treatment of cancer – Where do we stand?
Weber, D. D., Aminzadeh-Gohari, S., Tulipan, J., Catalano, L., Feichtinger, R. G., & Kofler, B. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2019.06.026 · Cited by 464
Mitochondria and cancer chemoresistance
Guerra, F., Arbini, A. A., & Moro, L. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.01.012 · Cited by 323
Metadata
- Authors
- Gasparre, G., Porcelli, A. M., Bonora, E., Pennisi, L. F., Toller, M., Iommarini, L., Ghelli, A., Moretti, M., Betts, C. M., Martinelli, G. N., Ceroni, A. R., Curcio, F., Carelli, V., Rugolo, M., Tallini, G., & Romeo, G.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2007-05-22
- Volume
- 104
- Issue
- 21
- Pages
- 9001-9006
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2048366336
- Cited by
- 316
- References
- 29
- FWCI
- 10.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.